CANDIDATE | INDICATIONPRE-CLINICALPHASE ONEPHASE TWOPHASE THREERIGHTSPARTNER

DMX-101
(XLHED)

Worldwide

espeRare logo

DMX-102
(Netherton Syndrome)

Worldwide

exicure logo

Additional Rare Skin
Disease Indications

Worldwide

exicure logo

collaborators
clinical trials

To learn more about our clinical studies of investigational therapies in XLHED, please visit our clinical trials page.